Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
24.35 HKD | -4.88% | -2.99% | +16.51% |
05-14 | Calliditas Therapeutics Partner Offers Nefecon in China; Shares Rise | MT |
05-14 | Everest Medicines Announces Commercial Launch and First Prescription for NEFECON in Mainland China | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.51% | 1.05B | |
+0.10% | 91.42B | |
+2.76% | 41.08B | |
-11.32% | 34.26B | |
+53.68% | 25.27B | |
-9.30% | 12.81B | |
-12.11% | 11.6B | |
-43.61% | 11.42B | |
+5.39% | 9.16B | |
-6.90% | 8.22B |
- Stock Market
- Equities
- 1952 Stock
- News Everest Medicines Limited
- Transcript : Calliditas Therapeutics AB, Everest Medicines Limited - Special Call